Laurent Higueret

Laurent is a Senior Investment Director in the Large Venture Fund at Bpifrance, the VC arm of the Public Investment Bank of France, in charge of healthcare and life sciences investments. He currently serves as a board director at Owkin (AI for medical research) and Voluntis (digital therapeutics). He is also a board observer at DNA Script (enzymatic DNA synthesis), Dynacure (antisense therapies), Enyo Pharma (NASH, HBV) and Poxel (T2D, NASH). Laurent also follows Bpifrance Participations’ investment in DBV Technologies (food allergies).

Before joining Bpifrance in 2014, he spent six years as an investment banker with BNP Paribas’ Healthcare M&A Group.

Laurent qualified as a Doctor of Pharmacy at the University of Bordeaux and holds a Master Degree in Financial Engineering from the EM Lyon Business School.